Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno
Stephan Windecker

Showing results (131-140 of 2,159) with videos related to

Pageof 216
Sort By:
JACC. Cardiovascular Interventions|January 4, 2023
Timing, Selection, Modulation, and Duration of P2Y<sub>12</sub> Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCIDavide Capodanno, Dominick J Angiolillo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Diabetes mellitus: the scary killer haunting silentlyDavide Capodanno, Dominick J Angiolillo
Thrombosis and Haemostasis|July 24, 2015
Management of adjunctive antithrombotic therapy in STEMI patients treated with fibrinolysis undergoing rescue or delayed PCIDavide Capodanno, Dominick J Angiolillo
Interventional Cardiology Clinics|November 26, 2016
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs?Davide Capodanno, Dominick J Angiolillo
Circulation. Cardiovascular Interventions|February 20, 2014
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventionsDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|January 10, 2019
Tailoring Antiplatelet Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: Navigating the UnknownDavide Capodanno, Dominick J Angiolillo
Circulation|May 31, 2012
Antithrombotic therapy in patients with chronic kidney diseaseDavide Capodanno, Dominick J Angiolillo
Journal of the American Heart Association|December 11, 2020
When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y<sub>12</sub> Inhibition Induced by TicagrelorDavide Capodanno, Dominick J Angiolillo
Thrombosis and Haemostasis|January 4, 2020
Pooling the Evidence at the Patient Level: End of the Bivalirudin Saga?Davide Capodanno, Dominick J Angiolillo
Circulation|November 30, 2020
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes MellitusDavide Capodanno, Dominick J Angiolillo
Pageof 216

Showing results (131-140 of 2,159) with videos related to

Sort By:
Pageof 216
JACC. Cardiovascular Interventions|January 4, 2023
Timing, Selection, Modulation, and Duration of P2Y<sub>12</sub> Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCIDavide Capodanno, Dominick J Angiolillo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Diabetes mellitus: the scary killer haunting silentlyDavide Capodanno, Dominick J Angiolillo
Thrombosis and Haemostasis|July 24, 2015
Management of adjunctive antithrombotic therapy in STEMI patients treated with fibrinolysis undergoing rescue or delayed PCIDavide Capodanno, Dominick J Angiolillo
Interventional Cardiology Clinics|November 26, 2016
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs?Davide Capodanno, Dominick J Angiolillo
Circulation. Cardiovascular Interventions|February 20, 2014
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventionsDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|January 10, 2019
Tailoring Antiplatelet Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: Navigating the UnknownDavide Capodanno, Dominick J Angiolillo
Circulation|May 31, 2012
Antithrombotic therapy in patients with chronic kidney diseaseDavide Capodanno, Dominick J Angiolillo
Journal of the American Heart Association|December 11, 2020
When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y<sub>12</sub> Inhibition Induced by TicagrelorDavide Capodanno, Dominick J Angiolillo
Thrombosis and Haemostasis|January 4, 2020
Pooling the Evidence at the Patient Level: End of the Bivalirudin Saga?Davide Capodanno, Dominick J Angiolillo
Circulation|November 30, 2020
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes MellitusDavide Capodanno, Dominick J Angiolillo
Pageof 216